腹腔镜结直肠切除口服联合静脉与单用静脉抗生素预防的随机临床试验
该随机临床试验在单一癌症中心纳入515例择期腹腔镜结直肠切除患者,比较术前口服甲硝唑与卡那霉素联合围术期静脉头孢美唑与单用静脉头孢美唑的SSI发生率。
要点
- 单用围术期静脉抗生素预防SSI不劣于联合术前口服方案
- 择期腹腔镜结直肠切除可考虑省略术前口服抗生素
核心结论
- 在择期腹腔镜结直肠癌切除患者中,单用围术期静脉抗生素预防SSI不劣于术前口服联合围术期静脉方案。
研究设计与样本
- 2013-2014年单中心随机临床试验,540例受邀中515例随机,符合方案分析为IV-only组256例与oral/IV组255例。
- 按手术类型、术前机械肠道准备、术前放化疗及糖尿病进行分层。
关键数值与推荐
- 主要终点为总体SSI率,次要终点包括切口感染、器官/腔隙感染、吻合口漏、腹腔脓肿、不良事件及术后并发症。
临床怎么用
- 择期腹腔镜结直肠切除可单用围术期静脉抗生素预防,无需常规联合术前口服抗生素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The use of oral prophylactic antibiotics for the prevention of surgical-site infection (SSI) in patients undergoing laparoscopic surgery for colorectal cancer is controversial. The aim of this RCT was to evaluate whether intravenous perioperative antibiotics are inferior to combined preoperative oral and perioperative intravenous antibiotics in this setting. METHODS: Patients undergoing elective laparoscopic colorectal resection in a single cancer centre were assigned randomly to combined preoperative oral antibiotics (metronidazole and kanamycin) and perioperative intravenous antibiotics (cefmetazole) (oral/IV group) or to perioperative intravenous antibiotics (cefmetazole) alone (IV-only group). Patients were stratified for the analyses based on type of operation (colonic surgery, anterior resection or abdominoperineal resection), preoperative use of mechanical bowel preparation, preoperative chemoradiotherapy and the presence of diabetes mellitus. The primary endpoint was the overall rate of SSI. Secondary endpoints were the rates of incisional site infection, organ/space infection, anastomotic leakage, intra-abdominal abscess, adverse events and postoperative complications. RESULTS: Of 540 patients offered participation in the trial in 2013-2014, 515 agreed to take part and were randomized. Some 256 patients in the IV-only group and 255 in the oral/IV group completed the treatment per protocol. The overall rate of SSI was 7·8 per cent (20 of 256) in the IV-only group and 7·8 per cent (20 of 255) in the oral/IV group, confirming that perioperative administration of intravenous antibiotics alone was not inferior to the combined regimen (P = 0·017). There were no differences in rates of incisional site infection (5·5 versus 5·9 per cent respectively), organ/space infection (2·3 versus 2·0 per cent) or other secondary endpoints between the two groups. CONCLUSION: Intravenous perioperative antimicrobial prophylaxis alone is not inferior to combined preoperative oral and intravenous perioperative prophylaxis with regard to SSI in patients with colorectal cancer undergoing elective laparoscopic resection. Registration number: UMIN000019339 ( http://www.umin.ac.jp/ctr/).
引用
- Ikeda A, Konishi T, Ueno M, et al. Randomized clinical trial of oral and intravenous versus intravenous antibiotic prophylaxis for laparoscopic colorectal resection. Br J Surg. 2016. PMID: 27550722. doi:10.1002/bjs.10281
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。